A sweeping US executive order by President Donald Trump to slash prescription drug prices to match international levels is ...

Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...

President Donald Trump put the pharmaceutical industry on notice early Monday with the signing of his "most favored nation" ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Trump’s tariffs hit the pharmaceutical industry hard, causing widespread disruption. Discover the effects on drug prices and production.

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.

Novo Nordisk's CEO, who led its boom driven by obesity and diabetes medications only to see that success stall, is stepping ...

Biosimilars, too, are expected to gain ground as healthcare systems worldwide look for cost-effective alternatives to ...

Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.

Squeezed by insurers and middlemen, independent pharmacists such as Jolley find themselves on the front lines of a tariff ...

Mumbai: Global pharma major Lupin Limited has appointed Punita Lal as an Additional Director (Non-Executive, Independent) to ...

On the heels of a production-tinged executive order earlier this month, the Trump administration is doubling down on efforts ...